Keith Wayne Ward, Chief Development Officer at REATA PHARMACEUTICALS INC (RETA), sold 4,750 shares at $59.48 ($283K) on 2018-11-01, disclosed to the SEC on 2018-11-01.
Open-market sale of $283k RETA by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RETA | SELL | 2019-01-03 | $448K | — | Filing → |
| RETA | SELL | 2018-11-08 | $636K | — | Filing → |
| RETA | SELL | 2018-10-24 | $813K | — | Filing → |